Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 5.04 AUD 0.4% Market Closed
Updated: Jun 3, 2024
MYX
/
Cash Flow Statement
/
Net Change in Cash

Mayne Pharma Group Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Net Change in Cash Peer Comparison

Comparables:
NEU
BOT
PBP
C
CU6
ALA

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Net Change in Cash
-AU$4.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Net Change in Cash
-AU$23.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Net Change in Cash
AU$9.6m
CAGR 3-Years
N/A
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Net Change in Cash
-AU$9.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Net Change in Cash
-AU$24.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arovella Therapeutics Ltd
ASX:ALA
Net Change in Cash
-AU$895.6k
CAGR 3-Years
35%
CAGR 5-Years
12%
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Net Change in Cash?
Net Change in Cash
-4.1m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Net Change in Cash amounts to -4.1m AUD.

What is Mayne Pharma Group Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
-210%

Over the last year, the Net Change in Cash growth was -210%.

ALPHA SPREAD
Join more than 143,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.